Detalhe da pesquisa
1.
Four cycles of R-CHOP followed by two applications of rituximab based on negative interim PET/CT: an analysis of a prospective trial.
BMC Cancer
; 22(1): 403, 2022 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35418080
2.
Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell-directed therapies.
Blood
; 138(9): 811-814, 2021 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34189565
3.
Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents.
Br J Haematol
; 169(4): 506-19, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25712263
4.
The novel proteasome inhibitor carfilzomib induces cell cycle arrest, apoptosis and potentiates the anti-tumour activity of chemotherapy in rituximab-resistant lymphoma.
Br J Haematol
; 162(5): 657-69, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23826755
5.
MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical models.
Anticancer Drugs
; 24(10): 1030-8, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23995855
6.
Evaluation safety and efficacy of immune checkpoint blockers (ICB) and radiotherapy combination versus ICB in non-small cell lung cancer patients with recurrence or metastasis: A systematic review and meta-analysis.
Cancer Med
; 12(13): 13928-13941, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37323098
7.
Early changes in soluble intracellular adhesion molecule-1 as prognostic biomarkers to immune checkpoint inhibitor.
Clin Transl Sci
; 16(8): 1396-1407, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37317057
8.
Early Changes of Serum Interleukin 14α Levels Predicts the Response to Anti-PD-1 Therapy in Cancer.
Clin Med Insights Oncol
; 17: 11795549231163369, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101524
9.
Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma.
Leukemia
; 37(1): 164-177, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36352191
10.
Prevalence of Myositis-Specific Autoantibodies and Myositis-Associated Autoantibodies in COVID-19 Patients: A Pilot Study and Literature Review.
Cureus
; 14(9): e29752, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36324355
11.
Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphoma.
J Cancer
; 13(3): 998-1004, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35154465
12.
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era.
Int J Hematol
; 116(3): 372-380, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35536508
13.
Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma.
Cell Death Dis
; 12(10): 900, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599153
14.
Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma.
Cancer Metab
; 8: 10, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32647571
15.
The adhesion molecule ICAM-1 in diffuse large B-cell lymphoma post-rituximab era: relationship with prognostic importance and rituximab resistance.
Aging (Albany NY)
; 13(1): 181-193, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33288735
16.
The SMAC mimetic LCL-161 displays antitumor activity in preclinical models of rituximab-resistant B-cell lymphoma.
Blood Adv
; 2(23): 3516-3525, 2018 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30530779
17.
Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development.
Oncotarget
; 9(3): 4020-4033, 2018 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29423101
18.
Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cells.
Oncotarget
; 8(8): 12741-12753, 2017 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28055975
19.
Successful treatment of an 82-year-old COVID-19 delta variant-infected patient with haemorrhagic stroke and active prostate cancer brain metastasis.
Clin Transl Discov
; 2(1): e20, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35464128
20.
Development and Testing of an Intelligent Pain Management System (IPMS) on Mobile Phones Through a Randomized Trial Among Chinese Cancer Patients: A New Approach in Cancer Pain Management.
JMIR Mhealth Uhealth
; 5(7): e108, 2017 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28743681